MIPT Scientists: Neural Networks Fail in Drug Development
Scientists at the Moscow Institute of Physics and Technology (MIPT) tested four popular AI tools for drug modeling and found systematic errors. The neural networks gave inconsistent results depending on the input format, and predicted physically impossible molecular geometries.
Google DeepMind
Chai Discovery
CNews12.08 · 18:02